ICU Medical (ICUI) said Monday it received regulatory clearances from the US Food and Drug Administration for its Plum Solo precision IV pump and updated versions of the Plum Duo precision IV pump and LifeShield infusion safety software.
The company said the approvals complete the initial release of its ICU Medical IV Performance Platform, allowing for the launch of its new category of precision IV pumps.
Price: 134.68, Change: -4.64, Percent Change: -3.33
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.